NCT01941992View on ClinicalTrials.gov

Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2018

Conditions

Head-and-neck Squamous Cell CarcinomaOral Mucositis

Interventions

DRUG

SAMITAL®

DRUG

Placebo sachets

Trial Locations (1)

35100

Radiotherapy Department, Istituto Oncologico Veneto, Padua

All Listed Sponsors

collaborator

Indena S.p.A

INDUSTRY

lead

Istituto Oncologico Veneto IRCCS

OTHER

NCT01941992 - Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients | Biotech Hunter | Biotech Hunter